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ABSTRACT 
 
 
Background 
Tolosa–Hunt syndrome (THS) related neurological 
symptoms are described in literature as “unilateral”, 
“recurrent”, “episodic”, “intense”, “severe”, “lancinating” or 
“stabbing” pain on the upper face and forehead and may be 
misdiagnosed due to the similarity of few symptoms and a 
significant number of common characteristics between both 
conditions. 
 
Aims 
The aim of this brief report is to indicate some important 
clinical insights related to Tolosa Hunt syndrome, and to 
give a frank account on the multidisciplinary approach on 
neurological-related symptomatology in maxillofacial 
region. 
 
Methods  
We analysed a selection of patients with such clinical 
picture. To better describe the proper management of 
clinical cases, we report a 50-year-old female reporting an 
history of two years of recurrent, severe stabbing pain 
around the right eye, prominence of her cheek and 
forehead. Her general dentist first mistakenly diagnosed 
toothache and, thus, it was subsequently misdiagnosed the 
trigeminal neuropathy (TN).  
 
Results  
Reported exemplificative case presented a mild ptosis, 
diplopia of the right eye, corneal reflex loss, paresthesia and 
hyperesthesia of upper part of left side of face. Magnetic 
resonance imaging (MRI) findings were suggestive of THS. 
Complete resolution of symptoms was achieved with oral 
Prednisolone and constant monitoring of symptoms. 
 
Conclusion 
THS may be added to the long list of differential diagnosis of 
TN and general dentist and oral surgeons should be 
informed about such rare causes of facial pain through 
continued medical education programs. 
 
Key Words 
Tolosa–Hunt syndrome, trigeminal neuralgia, ocular 
diseases 
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Implications for Practice:  
1. What is known about this subject?  
Tolosa–Hunt syndrome (THS) related neurological 
symptoms are uncommon and they can be misunderstood 
and confused with Trigeminal neuralgia (TN). 
 
2. What new information is offered in this report? 
In this brief report we indicate some important clinical 
insights related to Tolosa Hunt syndrome, and we also give 
a frank account on the multidisciplinary approach on 
neurological-related symptomatology in maxillofacial 
region. 
 
3. What are the implications for research, policy, or 
practice?  
THS may be added to the long list of differential diagnosis of 
TN to avoid wrong diagnosis and treatments. 
 
Background 
Trigeminal neuralgia (TN) is a recurrent, sharp, superficial, 
sudden, severe, stabbing, pain in the distribution of one or 
more branches of the fifth cranial nerve more commonly 
affecting the maxillary and mandibular branches but rarely 
involving the ophthalmic division of the trigeminal nerve.
1-3
 
TN pain severity is often correlated with reduced measures 
of daily functioning, well-being, sleep, mood and overall 
health status, thereby making profound impact on quality of 
life (QOL) by preventing the patient from speaking, eating, 
drinking, touching or washing of the face and brushing 
teeth.
3,4
 
 
Despite the clarity of painful symptoms of TN, as defined by 
International Association of Study of Pain (IASP) and the 
International Classification of Headache Disorders (ICHD), 
there are significantly common characteristics between TN 
and other painful conditions of the maxillofacial region.
5
 As 
the pain of TN seems to be arising from jaws, dental or oral 
structures, most patients initially seek a general dentist for 
management.
6
 It has been reported that majority of 
patients presenting at tertiary care centers for treatment of 
various facial pain had previously been misdiagnosed and 
had undergone irreversible dental treatment.
7,8
 
Paradoxically, most general dentists know very little about 
the other causes of facial pain and often tend to 
overdiagnose TN as it is often the only diagnosis apart from 
dental causes which they are familiar with.
5,9
 
 
TN pain has a long list of differential diagnoses as a number
 
of pathological conditions affecting the sinuses, teeth, 
temporo-mandibular
 
joints, eyes, nose, and the neck may 
present with similar symptoms namely Cluster headache, 
SNUCT syndrome (Short lasting, unilateral, neuralgiform 
headache with conjunctival injection and tearing), Chronic 
paroxysmal hemicranias, Cracked tooth syndrome, Jabs and 
jolts syndrome, Post-herpetic neuralgia, Gaint cell arteritis.
10
 
Tolosa–Hunt syndrome (THS) an extremely rare disorder 
characterized by recurrent paroxysms of severe and 
unilateral periorbital or hemicraneal pain in the distribution 
of the ophthalmic and maxillary division of the trigeminal 
nerve associated with ophthalmoplegia, ipsilateral ocular 
motor nerve palsies, oculosympathetic paralysis, and 
sensory loss in the first division of the 5
th
 cranial nerve.
11,12
 
THS may be misdiagnosed as TN due to the similarity of few 
symptoms and a significant number of common 
characteristics between both conditions.
13
 
 
We report a case of THS as an addition to the long list of 
differential diagnosis of TN among patients presenting at 
oral medicine department of Khyber college of Dentistry 
Peshawar. 
 
Case details 
A 50-year-old female lady presented to our department in 
October 2014 with two years history of recurrent, severe 
stabbing pain around the right eye, prominence of her 
cheek and forehead. She consulted her general dentist for 
management when her symptoms initially developed two 
years ago, mistaking it for toothache. The general dentist 
performed a few dental procedures in the upper jaw to 
relieve her pain but without any success. Suspecting TN as a 
cause the patient was put on carbamezapine 200mg but 
that too did not provide any relief in symptoms. The patient 
was subsequently referred to an oral surgeon. Based on the 
history of her symptoms, the patient was labeled as having 
typical TN and was offered neurectomy and alcohol 
injection as treatment options since the pain was not 
responding to anticonvulsants. She declined to undergo 
these treatment options offered by the oral surgeon and 
continued live a life of pain and suffering while taking any 
and every over the counter analgesics to relieve her pain. 
Meanwhile there was a spontaneous remission in her 
symptoms and she remained pain free for more than six 
months. The patient presented to us after being referred by 
the oral surgeon for experiencing recurrence of her painful 
symptoms for a few months. 
 
 On clinical examination she had mild ptosis and diplopia of 
the right eye. The patient had a corneal reflex loss, and also 
paresthesia and hyperesthesia of upper part of left side of 
face which was significant of involvement of ophthalmic 
branch of trigeminal nerve. Ophthalmologist opinion was 
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taken to rule out any other cause of headache. Funduscopy 
examination was within normal range. 
 
A Multiplanar MRI imaging through brain acquiring T1 and 
T2 weighted images with and without contrast was done, 
that revealed 1×1.2×1cm homogeneously enhancing extra 
axial lesion involving the right orbital apex with extensions 
into right cavernous sinus suggestive of Tolosa Hunt 
Syndrome (Figure 1). 
 
The patient was treated with oral Prednisolone (Deltacortril 
5mg tablets) and showed significant relief of symptoms 
within 48–72 hours. Complete resolution of her ptosis as 
well as the oculomotor nerve palsy was achieved within one 
week. Patient was followed-up for six months and showed 
no recurrence of symptoms till her last evaluation visit. 
 
Discussion 
THS is an extremely rare condition with an estimated annual 
incidence of one case per million per year.
14
 Originally 
reported by E Tolosa in 1954 in a (a 47-year-old man with 
self-limited left orbital pain. The pain recurred after several 
months and became associated with ptosis and 
subsequently total ophthalmoplegia.
15
 Later, on in 1961 W. 
E Hunt reported six similar cases and they concluded that 
the process was an inflammatory reaction limited to the 
cavernous sinus and that corticosteroid therapy was 
beneficial.
16
 Five years later in 1966, the condition was 
finally termed as “Tolosa-Hunt syndrome” by Smith and 
Taxdal as they described five more cases and stressed the 
importance of steroid administration as a diagnostic 
test.
17,18
 
 
According to Modified Revised IHS headache classification 
of 2004, THS is now described as “An episodic orbital pain 
associated with paralysis of one or more of the third, fourth 
and/or sixth cranial nerves which usually resolves 
spontaneously but tends to relapse and remit” with the 
following diagnostic criteria:
18
 
 
A. One or more episodes of unilateral orbital pain persisting 
for weeks if untreated.  
B. Paresis of one or more of the third, fourth and/or sixth 
cranial nerves and/or demonstration of granulomas by MRI 
or biopsy.  
C. Paresis coincides with the onset of pain or follows it 
within two weeks.  
D. Pain and paresis resolve within 72h when treated 
adequately with corticosteroids.  
E. Other causes have been excluded by appropriate 
investigations.  
Carotid-cavernous fistulae, pituitary adenomas, 
vasculopathic cranial neuropathy, aspergillus invasion, 
Wegener's granulomatosis, sarcoidosis, lymphoma and 
ophthalmoplegic migraine may be included in the extended 
list of differential diagnosis of any steroid responsive painful 
ophthalmoplegia.
16-18
 It is important to mention that 
meningiomas do not resolve with steroid therapy, 
sarcoidosis and lymphoma often have systemic symptoms 
whereas vascular abnormalities such as arteritides, carotid-
cavernous fistulae, ophthalmoplegic migraines and 
aneurysms are not associated with masses in the cavernous 
sinus or orbital apex.
15.20
 
 
In 2006 Shim KW, Moon JC et al reported the first case of 
THS misdiagnosed as TN and Atypical facial pain. They 
emphasized that THS may be misdiagnosed as TN and 
atypical facial pain due to the similarity of few symptoms 
and a significant number of common characteristics 
between both conditions.
13
 To the best of our knowledge 
ours was probably the second case of THS misdiagnosed as 
TN due to similarity of presentation. 
 
Despite the fact that THS and TN is usually described in 
literature as “unilateral”, “recurrent”, “episodic”, “intense”, 
“severe”, “lancinating” or “stabbing” pain on the upper face 
and forehead yet neither are mentioned in the long lists of 
differential diagnosis of either conditions.
5,10,18
 
 
Future therapies should be directed toward the 
immunomodulatory activity of mesenchymal stem cells 
(MSCs).
19
 Inflammation must be excluded from the potential 
causes of the described symptomatology, in fact, oxidative 
stress,
20-23
 tumor-related inflammation,
24,25
 and syndromic 
conditions affecting oral and perioral tissues
26
 are an 
important cause of secondary TN. New treatments will be 
directed on local drug delivery functionalized scaffolds and 
active principles delivered on site.
27-30
 
 
Conclusion 
Lack of knowledge may lead to delayed or erroneous 
diagnosis and unsuitable or unnecessary treatment 
interventions as most general dentists know very little 
about the other causes of facial pain. It is recommended 
that THS may be added to the long list of differential 
diagnosis of TN and general dentist and oral surgeons 
should be informed about such rare causes of facial pain 
through continued medical education programs. 
 
References 
1. Zakrzewska JM. Differential diagnosis of facial pain and 
 
 
146 
 
[AMJ 2018;11(2):143-147] 
 
 
guidelines for management. Br J Anaesth. 
2013;111(1):95–104.  
2. Ali M, Ansari SR, Khan MP, et al. Microvascular 
decompression for idiopathic trigeminal neuralgia: 
Ultimate solution to the management dilemma. Pak Oral 
Dent J. 2009:29(2):193–196. 
3. Shah SA, Murad N, Salaar A, et al. Trigeminal neuralgia: 
Analysis of pain distribution. Pak Oral Dent J. 
2008;28:37–41. 
4. Tolle T, Duke E, Sadosky A. Patient burden of trigeminal 
neuralgia: results from a cross-sectional survey of health 
state impairment and treatment patterns in European 
countries. Pain Pract. 2006;6:153–60. 
5. Zakrzewska JM, Padfield D. The patient’s journey 
through trigeminal neuralgia. Pain: Clinical Updates. 
2014;22(1):1–8. 
6. Baskaran K. A systemic review of patients appearing to 
dental professionals with trigeminal neuralgia arising 
from intracranial tumours. Int J Sci Res. 2017:6(5):72–76. 
7. Benoliel R, Eliav E. Neuropathic orofacial pain. Oral 
Maxillofac Surg Clin North Am. 2008;20:237–254. 
8. B. Perić, Zore IF, Vidaković B, et al. Trigeminal neuralgia 
– case and treatment analysis at the Department of Oral 
Surgery of the University Hospital Dubrava. Coll 
Antropol. 2014;38(2):685–689. 
9. Koopman JS, Dieleman JP, Huygen FJ, et al. Incidence of 
facial pain in the general population. Pain. 
2009;147:122–7. 
10. Nurmikko TJ, Eldridge PR. Trigeminal neuralgia—
pathophysiology, diagnosis and current treatment. Br J 
Anaesth. 2001;87:117–132. 
11. Colnaghi S, Versino M, Marchioni E, et al. ICHD-II 
diagnostic criteria for Tolosa-Hunt syndrome in 
idiopathic inflammatory syndromes of the orbit and/or 
the cavernous sinus. Cephalalgia. 2008;28:577–84. 
12. Gladstone JP. An approach to the patient with painful 
ophthalmoplegia, with a focus on tolosa-hunt syndrome. 
Curr Pain Headache Rep. 2007;11:317–325. 
13. Shim KW, Moon JC, Yoon KB, et al. Hemifacial pain 
accompanied with delayed ipsilateral abducens nerve 
palsy: Tolosa hunt syndrome. A case report. Korean J 
Pain. 2006:19(1):104–106. 
14. Patel S, Sankhe P, Dave D, et al. Tolosa Hunt syndrome: a 
rare syndrome. Int J Res Med Sci. 2015;3:3914-6. 
15. Tolosa E. Periarteritic lesions of the carotid siphon with 
the clinical features of a carotid infraclinoid aneurysm. J 
Neurol Neurosurg Psychiatry. 1954;17:300–2. 
16. Hunt WE, Meagher JN, Le Fever HE, et al. Painful 
ophthalmoplegia. Its relation to indolent inflammation 
of the cavernous sinus. Neurology. 1961;11:56–62. 
17. Smith JL, Taxdal DSR. Painful ophthalmoplegia. The 
Tolosa-Hunt syndrome. Am J Ophthalmol. 
1966;61:1466– 72. 
18. Kline LB, Hoyt WF. The Tolosa-Hunt syndrome. J Neurol 
Neurosurg Psychiatry. 2001;71:577-82.  
19. Tatullo M, Falisi G, Amantea M, et al. Dental pulp stem 
cells and human periapical cyst mesenchymal stem cells 
in bone tissue regeneration: Comparison of basal and 
osteogenic differentiated gene expression of a newly 
discovered mesenchymal stem cell lineage. J Biol Regul 
Homeost Agents. 2015;29(3):713–8. PMID: 26403412 
20. Tatullo M, Gentile S, Paduano F, et al. Crosstalk between 
oral and general health status in e-smokers. Medicine 
(Baltimore). 2016;95(49):e5589. doi: 
10.1097/MD.0000000000005589 
21. Tatullo M, Simone GM, Tarullo F, et al. Antioxidant and 
antitumor activity of a bioactive polyphenolic fraction 
isolated from the brewing process. Sci Rep. 
2016;6:36042. doi: 10.1038/srep36042 
22. Marrelli M, Gentile S, Palmieri F, et al. Correlation 
between Surgeon's experience, surgery complexity and 
the alteration of stress related physiological parameters. 
PLoS One. 2014;9(11):e112444. doi: 
10.1371/journal.pone.0112444. 
23. Tatullo M, Marrelli M, Scacco S, et al. Relationship 
between oxidative stress and "burning mouth 
syndrome" in female patients: a scientific hypothesis. 
Eur Rev Med Pharmacol Sci. 2012;16(9):1218–21. PMID: 
23047505 
24. Tatullo M, Marrelli M, Amantea M, et al. Bioimpedance 
detection of oral lichen planus used as preneoplastic 
model. J Cancer. 2015;6(10):976–83. doi: 
10.7150/jca.11936. eCollection 2015. 
25. Inchingolo F, Tatullo M, Abenavoli FM, et al. Non-
Hodgkin lymphoma affecting the tongue: unusual intra-
oral location. Head Neck Oncol. 2011;3:1. doi: 
10.1186/1758-3284-3-1. 
26. Inchingolo F, Tatullo M, Abenavoli FM, et al. Non-
syndromic multiple supernumerary teeth in a family unit 
with a normal karyotype: case report. Int J Med Sci. 
2010;7(6):378–84. doi:10.7150/ijms.7.378 
27. Aulino P, Costa A, Chiaravalloti E, et al. Muscle 
extracellular matrix scaffold is a multipotent 
environment. Int J Med Sci. 2015;12(4):336–40. doi: 
10.7150/ijms.10761 
28. Perniconi B, Coletti D, Aulino P, et al. Muscle acellular 
scaffold as a biomaterial: effects on C2C12 cell 
differentiation and interaction with the murine host 
environment. Front Physiol. 2014;5:354. doi: 
10.3389/fphys.2014.00354. 
29. Marrelli M, Pujia A, Palmieri F, et al. Innovative approach 
for the in vitro research on biomedical scaffolds 
 
 
147 
 
[AMJ 2018;11(2):143-147] 
 
 
designed and customized with CAD-CAM technology. Int 
J Immunopathol Pharmacol. 2016;29(4):778–783. doi: 
10.1177/0394632016646121 
30. Paduano F, Marrelli M, Amantea M, et al. Adipose tissue 
as a strategic source of mesenchymal stem cells in bone 
regeneration: A topical review on the most promising 
craniomaxillofacial applications. Int J Mol Sci. 
2017;18(10)2140. doi: 10.3390/ijms18102140.  
 
PEER REVIEW 
Not commissioned. Peer reviewed. 
 
CONFLICTS OF INTEREST 
The authors declare that they have no competing interests. 
 
FUNDING 
None 
 
ETHICS COMMITTEE APPROVAL 
This study was approved by internal committee of 
Department of Oral & Maxillofacial Surgery, College of 
dentistry, University of Hail, KSA. 
 
Figure 1: A Multiplaner MRI imaging with contrast through 
brain acquiring T1 and T2 weighted images that revealed 1 
x 1.2 x1 cm homogeneously enhancing extra axial lesion 
involving the right orbital apex with extensions into right 
cavernous sinus suggestive of Tolosa Hunt Syndrome 
 
 
